AURIMOD Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series A
- (In Progress)
- Investors
-
5
AURIMOD General Information
Description
Developer of a medical neurostimulation device designed to treat chronic pain through auricular vagus nerve stimulation. The company offers a wearable, CE-marked device that stimulates the vagus nerve behind the ear to activate the body's natural pain-regulating mechanisms, enabling patients and healthcare providers to manage chronic pain through a non-invasive, drug-free alternative to medication and invasive procedures.
Contact Information
Website
www.aurimod.comCorporate Office
- Modecenterstrasse 22/D29
- Vienna, 1030
- Austria
Corporate Office
- Modecenterstrasse 22/D29
- Vienna, 1030
- Austria
AURIMOD Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | In Progress | Startup | ||||
| 5. Early Stage VC | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Grant | 01-Oct-2019 | Completed | Generating Revenue | |||
| 2. Grant | 23-Jun-2018 | $889K | Completed | Generating Revenue | ||
| 1. Grant | Completed | Startup |
AURIMOD Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AURIMOD Patents
AURIMOD Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026215105-A1 | Transcutaneous nerve stimulation patch arrangement | Pending | 07-Apr-2025 | ||
| EP-4674470-A1 | Device for auricular nerve stimulation | Active | 01-Jul-2024 | ||
| EP-4674470-B1 | Device for auricular nerve stimulation | Active | 01-Jul-2024 | ||
| EP-4674470-C0 | Device for auricular nerve stimulation | Active | 01-Jul-2024 | ||
| ES-3073236-T3 | Device for auricular nerve stimulation | Active | 01-Jul-2024 | A61N1/36036 |
AURIMOD Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AURIMOD Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | |||
| European Union | Government | |||
| Convergence Partners (Switzerland) | Venture Capital | Minority | ||
| Gold Track | Accelerator/Incubator | |||
| Situlus Holding | Venture Capital | Minority |
AURIMOD FAQs
-
When was AURIMOD founded?
AURIMOD was founded in 2015.
-
Where is AURIMOD headquartered?
AURIMOD is headquartered in Vienna, Austria.
-
What is the size of AURIMOD?
AURIMOD has 22 total employees.
-
What industry is AURIMOD in?
AURIMOD’s primary industry is Therapeutic Devices.
-
Is AURIMOD a private or public company?
AURIMOD is a Private company.
-
What is AURIMOD’s current revenue?
The current revenue for AURIMOD is .
-
Who are AURIMOD’s investors?
European Innovation Council, European Union, Convergence Partners (Switzerland), Gold Track, and Situlus Holding have invested in AURIMOD.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
